At the final KEYS broadcast of the year, we’ll be taking time out to think about what we learned from the story of 2024, and going on the lookout for clues as to what 2025 has in store.
One of this century’s biggest game-changers will likely be a novel drug class that’s showing unprecedented success, or the promise of it, in treating some of the world’s most prevalent conditions.
Younger people (particularly young women) are the most likely to feel depressed and take time off work due to stress according to an Ipsos report for World Mental Health Day 2024
The advent of groundbreaking therapies in the metabolic sector, including GLP-1, offers substantial opportunities for pharmaceutical companies, yet accurately estimating the size of these emerging markets, marked by significant unmet clinical needs, presents distinct challenges.
Across 31 countries 44% rate the quality of the healthcare they receive as good, but access to treatment and not enough staff are seen as major systemic challenges
